Clinical trials
Recruiting Observational Primary Immunodeficiency Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 2 |
| 2011 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 2 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 20 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 9 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | 1 |
| Icahn School of Medicine at Mount Sinai | 1 |
| Imagine Institute | 1 |
| Institut National de la Santé Et de la Recherche Médicale, France | 1 |
| Paul Szabolcs | 1 |
| Shwachman-Diamond Syndrome Alliance Inc | 1 |
| Takeda | 1 |
| University Children's Hospital, Zurich | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Primary Immunodeficiency Diseases | 20 |
| Immune System Diseases | 4 |
| Immunologic Deficiency Syndromes | 4 |
| Autoimmune Diseases | 3 |
| Congenital Bone Marrow Failure Syndromes | 2 |
| Inflammatory Bowel Diseases | 2 |
| Mycoses | 2 |
| Addison Disease | 1 |
| Adrenoleukodystrophy | 1 |
| Anemia, Diamond-Blackfan | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.